Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Matti Lehtinen, Penelope Gray, Karolina Louvanto & Simopekka Vänskä. (2022) In 30 years, gender-neutral vaccination eradicates oncogenic human papillomavirus (HPV) types while screening eliminates HPV-associated cancers. Expert Review of Vaccines 21:6, pages 735-738.
Read now
Read now
Sandra D Isidean, Joseph E Tota, Julien A Gagnon & Eduardo L Franco. (2015) Human papillomavirus vaccines: key factors in planning cost-effective vaccination programs. Expert Review of Vaccines 14:1, pages 119-133.
Read now
Read now
Articles from other publishers (13)
Prasanna Honnavar, Edmond Mansoor, Cherie Tulloch, Uttam Udayan, Isabella Cosmello, Purva Patel & Ashley Bersma. (2023) Cervical Cancer and Human Papillomavirus Awareness among Women in Antigua and Barbuda. Medicina 59:7, pages 1230.
Crossref
Crossref
Chuanyun Xu, Mengwei Li, Gang Li, Yang Zhang, Chengjie Sun & Nanlan Bai. (2022) Cervical Cell/Clumps Detection in Cytology Images Using Transfer Learning. Diagnostics 12:10, pages 2477.
Crossref
Crossref
Farhan Alshammari & Kashif Ullah Khan. (2022) Knowledge, attitudes and perceptions regarding human papillomavirus among university students in Hail, Saudi Arabia. PeerJ 10, pages e13140.
Crossref
Crossref
Linda Nyanchoka, Andreea Damian & Mari Nygård. (2022) Understanding facilitators and barriers to follow-up after abnormal cervical cancer screening examination among women living in remote areas of Romania: a qualitative study protocol. BMJ Open 12:2, pages e053954.
Crossref
Crossref
B. Chitra & S. S. Kumar. (2021) Recent advancement in cervical cancer diagnosis for automated screening: a detailed review. Journal of Ambient Intelligence and Humanized Computing 13:1, pages 251-269.
Crossref
Crossref
Sharon J.B. Hanley, Hiromasa Fujita, Satomi Aoyama-Kikawa, Mitsunori Kasamo, Toshihiko Torigoe, Yoshihiro Matsuno & Sakuragi Noriaki. (2021) Evaluation of partial genotyping with HPV16/18 for triage of HPV positive, cytology negative women in the COMPACT study. Journal of Gynecologic Oncology 32:6.
Crossref
Crossref
Neerja Bhatla & Seema Singhal. (2020) Primary HPV screening for cervical cancer. Best Practice & Research Clinical Obstetrics & Gynaecology 65, pages 98-108.
Crossref
Crossref
Neerja Bhatla, Seema Singhal, Usha Saraiya, Shikha Srivastava, Sarita Bhalerao, Saritha Shamsunder, Niranjan Chavan, Partha Basu, CN Purandare, P Agarwal, M Arora, N Bhatla, P Basu, S Bhalerao, S Batra, D Banerjee, N Chavan, B Dhorepatil, B Gupta, G Gandhi, K Gupta, P Ganesh, S Joshi, A Kriplani, R Khanna, S Kumar, A Maheshwari, J Meena, B Nayak, J Natarajan, R Pai, R Pathak, RB Prabhu, A Peedicayil, S Rajaram, R Sekhon, S Shamsunder, S Srivastava, U Singh, S Singhal, U Saraiya & V Zutshi. (2019) Screening and management of preinvasive lesions of the cervix: Good clinical practice recommendations from the Federation of Obstetrics and Gynaecologic Societies of India (FOGSI). Journal of Obstetrics and Gynaecology Research.
Crossref
Crossref
Mélanie Drolet, Élodie Bénard, Norma Pérez, Marc Brisson, Hammad Ali, Marie-Claude Boily, Vincenzo Baldo, Paul Brassard, Julia M L Brotherton, Denton Callander, Marta Checchi, Eric P F Chow, Silvia Cocchio, Tina Dalianis, Shelley L Deeks, Christian Dehlendorff, Basil Donovan, Christopher K Fairley, Elaine W Flagg, Julia W Gargano, Suzanne M Garland, Nathalie Grün, Bo T Hansen, Christopher Harrison, Eva Herweijer, Teresa M Imburgia, Anne M Johnson, Jessica A Kahn, Kimberley Kavanagh, Susanne K Kjaer, Erich V Kliewer, Bette Liu, Dorothy A Machalek, Lauri Markowitz, David Mesher, Christian Munk, Linda Niccolai, Mari Nygård, Gina Ogilvie, Jeannie Oliphant, Kevin G Pollock, Maria Jesús Purriños-Hermida, Megan A Smith, Marc Steben, Anna Söderlund-Strand, Pam Sonnenberg, Pär Sparen, Clare Tanton, Cosette M Wheeler, Petra J Woestenberg & Bo Nancy Yu. (2019) Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. The Lancet 394:10197, pages 497-509.
Crossref
Crossref
Simopekka Vänskä, Johannes A. Bogaards, Kari Auranen, Matti Lehtinen & Johannes Berkhof. (2019) Fast approximate computation of cervical cancer screening outcomes by a deterministic multiple-type HPV progression model. Mathematical Biosciences 309, pages 92-106.
Crossref
Crossref
Hoda Jradi & Amen Bawazir. (2019) Knowledge, attitudes, and practices among Saudi women regarding cervical cancer, human papillomavirus (HPV) and corresponding vaccine. Vaccine 37:3, pages 530-537.
Crossref
Crossref
Anthony E Rizzo & Sarah Feldman. (2018) Update on primary HPV screening for cervical cancer prevention. Current Problems in Cancer 42:5, pages 507-520.
Crossref
Crossref
Joseph E. Tota, James Bentley, Jennifer Blake, François Coutlée, Máire A. Duggan, Alex Ferenczy, Eduardo L. Franco, Michael Fung-Kee-Fung, Walter Gotlieb, Marie-Hélène Mayrand, Meg McLachlin, Joan Murphy, Gina Ogilvie & Sam Ratnam. (2017) Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm. Preventive Medicine 98, pages 5-14.
Crossref
Crossref